
Roberto De Gregorio
Articles
-
Jul 1, 2024 |
jnm.snmjournals.org | Cinzia Imberti |Roberto De Gregorio |Joshua A. Korsen |Tran Hoang
Thank you for your interest in spreading the word on Journal of Nuclear Medicine. NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.
-
May 23, 2024 |
jnm.snmjournals.org | Cinzia Imberti |Roberto De Gregorio |Tran Hoang |Joshua A. Korsen
Thank you for your interest in spreading the word on Journal of Nuclear Medicine. NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.
-
Apr 28, 2024 |
biorxiv.org | David Bauer |Roberto De Gregorio |Edwin Charles Pratt |Abram Bell
AbstractPurpose: The radionuclide pair cerium-134/lanthanum-134 (134Ce/134La) was recently proposed as a suitable diagnostic counterpart for the therapeutic alpha-emitter actinium-225 (225Ac).
-
Nov 29, 2023 |
jneurosci.org | Roberto De Gregorio |Claudia De Sanctis |Rosa Maria Piscitelli |Carla Perrone-Capano
Citation Tools miR-218 Promotes Dopaminergic Differentiation and Controls Neuron Excitability and Neurotransmitter Release through the Regulation of a Synaptic-Related Genes Network Journal of Neuroscience 43 (48) 8104-8125; DOI: 10.1523/JNEUROSCI.0431-23.2023 Citation Manager Formats Recaptcha requires verification.
-
Nov 10, 2023 |
jnm.snmjournals.org | David Bauer |Lukas M Carter |Mohamed I. Atmane |Roberto De Gregorio
A therapy study was conducted with [212Pb]Pb-DO3A-PEG7-Tz (single administration) comprising 5 arms (n = 8 per cohort) with 2 control and 3 therapeutic groups. The 2 control arms consisted of one group that received only 5B1-TCO and one that received an unspecific IgG-TCO mAb followed by administration of 1.1 MBq of [212Pb]Pb-DO3A-PEG7-Tz 3 d later.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →